Genes with a potential role in doxorubicin-resistance following vorinostat treatment.

There were 405 unique genes differentially expressed (fold change >1.5, adjusted p<0.1) in both SK-N-SH and SK-N-Be(2)C DoxR-v cells, but not in the DoxR or WT-v lines. The complete list of all 405 unique DEGs is available in Table S1, while the subset of those genes with the greatest differential expression (fold change>2) is listed here.